{
    "name": "diatrizoate",
    "comment": "Rx",
    "other_names": [
        "Cystografin"
    ],
    "classes": [
        "Iodinated Contrast Media",
        "Contrast Media",
        "Ionic/High Osmolality"
    ],
    "source": "https://reference.medscape.com/drug/hypaque-renodip-diatrizoate-343768",
    "pregnancy": {
        "common": [
            "Pregnancy Category: C",
            "Lactation: Excreted in breast milk, use caution"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "Lactation: Excreted in breast milk, use caution"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to diatrizoate",
                "Intravascular or intrathecal use"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents",
                "Iodine sensitivity",
                "Use intravascular techniques that minimize risk for extravasation",
                "Use caution in hepatic impairment, heart failure, hypertension, multiple myeloma, hyperthyroidism, pheochromocytoma, renal impairment, sickle cell disease, subarachnoid hemorrhage, and thromboembolism"
            ],
            "specific": [
                {
                    "type": "FDA MedWatch ",
                    "description": [
                        "March 30, 2022: ",
                        "FDA",
                        " recommended newborns and children aged â‰¤3 years have follow-up thyroid monitoring within 3 weeks after receiving iodinated contrast media (ICM) for X-rays and other medical imaging procedures ",
                        "Published studies found underactive thyroid and temporary decreases in thyroid hormone levels were uncommon; however, if identified and treated early, future complications may be prevented ",
                        "Appropriately monitor for signs and symptoms of hypothyroidism and decreased thyroid hormone levels following ICM exposure; consider evaluating thyroid function within 3 weeks, especially in term and preterm neonates and children with some underlying conditions ",
                        "If thyroid dysfunction detected, treat and monitor thyroid function as needed to avoid future complications ",
                        "Certain pediatric patients are at increased risk, including newborns or have very low birth weight, prematurity, or presence of cardiac or other conditions (eg, requiring care in neonatal or pediatric ICUs) ",
                        "Patients with cardiac conditions may be at greatest risk since they often require high doses of contrast during invasive cardiac procedures "
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Anaphylactoid reactions manifested as edema of the face and glottis",
            "percent": null
        },
        {
            "name": "respiratory distress",
            "percent": null
        },
        {
            "name": "confusion or shock that can be fatal",
            "percent": null
        }
    ]
}